ArticleFrontiers in immunology2024

Refining patient selection for next-generation immunotherapeutic early-phase clinical trials with a novel and externally validated prognostic nomogram.

Agnese Losurdo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.